Back

Association between RNA modification N6-methyladenosine (m6A) and neurological outcome after cardiac arrest

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (1) - RNA biology, epigenetic modifications, and cardiovascular risk Genetics, Epigenetics, ncRNA ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Miss Victoria Stopa

Luxembourg Institute of Health, Strassen (Luxembourg)

8 More presentations in this session

Presentation thumbnail
Discussant - RNA biology, epigenetic modifications, and cardiovascular risk
Presentation thumbnail
RNA elongation- a potential new molecular approach for the treatment of early atherosclerosis
Doctor K. Kokot (Leipzig, DE)
Abstract
Presentation thumbnail
Comparative study on transcriptomic differences between cardiomyocytes and cardiomyocyte nuclei
Doctor H. Li (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
DNase II regulates pro-inflammatory activation of macrophages, contributing to the pathogenesis of insulin resistance in obese mice
Ms O. Bavuu (Osaka, JP)
Abstract Slides Video
Presentation thumbnail
DNA methylome analysis reveals distinct episignatures in bicuspid aortic valve
Mr D. Bagues Castro (Oviedo, ES)
Abstract Slides Video

Access the full session

Session thumbnail
New perspectives in cardiology (1) - RNA biology, epigenetic modifications, and cardiovascular risk

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources